Skip to main content
ImmunomePortfolio News

Immunome Appoints Bob Lechleider, M.D., as Chief Medical Officer

By October 19, 2023December 12th, 2024No Comments

Immunome Appoints Bob Lechleider, M.D., as Chief Medical Officer

– Seasoned biotechnology executive and board-certified physician in medical oncology joins executive team as Immunome advances growing pipeline of cancer therapies 

See more here